CCC
ABEO icon

Cable Car Capital’s Abeona Therapeutics ABEO Stock Holding History

Cable Car Capital’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.5M Buy
3,007,329
+507,329
+20% +$2.54M 4.65% 4
2025
Q4 		$13.2M Buy
2,500,000
+1,900,000
+317% +$9.56M 0.44% 15
2025
Q3 		$3.17M Buy
+600,000
New +$3.81M 1.36% 14

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cable Car Capital's ABEO Position: Q1 2026 in Review

Cable Car Capital increased its Abeona Therapeutics (ABEO) stake by 20% in Q1 2026, buying an estimated $2.54M and bringing the position to 3,007,329 shares worth $13.5M. The position accounts for 4.65% of the portfolio, ranked #4.

Cable Car Capital first reported a position in ABEO in Q3 2025 and has held it in 3 quarters since. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Cable Car Capital held 3,007,329 shares of Abeona Therapeutics worth $13.5M as of Q1 2026.
  • Cable Car Capital bought 507,329 Abeona Therapeutics shares in Q1 2026, an estimated $2.54M.
  • Abeona Therapeutics made up 4.65% of Cable Car Capital's portfolio in Q1 2026, its #4 holding.
  • Cable Car Capital first reported a position in Abeona Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Cable Car Capital's 13F filing for Q1 2026, filed 15 May 2026.